In suspected vitamin B12 deficiency, which additional lab finding supports the diagnosis besides low serum B12?

Prepare for the Hematologic, Immunologic, and Neoplastic Disorders Test. Study with flashcards and multiple-choice questions, each with explanations and hints. Get ready for your exam!

Multiple Choice

In suspected vitamin B12 deficiency, which additional lab finding supports the diagnosis besides low serum B12?

Explanation:
When you suspect vitamin B12 deficiency, a rise in methylmalonic acid is a key supportive finding because B12 is a cofactor for the conversion of methylmalonyl-CoA to succinyl-CoA. Without enough B12, methylmalonyl-CoA accumulates and is converted to methylmalonic acid, which levels rise in serum (or urine). This makes methylmalonic acid a more specific indicator for B12 deficiency and helps distinguish it from folate deficiency, which does not elevate methylmalonic acid (though both deficiencies can raise homocysteine). The other options aren’t as specific: ferritin can be influenced by inflammation and iron stores, and LDH is a non-specific marker that doesn’t pinpoint B12 deficiency.

When you suspect vitamin B12 deficiency, a rise in methylmalonic acid is a key supportive finding because B12 is a cofactor for the conversion of methylmalonyl-CoA to succinyl-CoA. Without enough B12, methylmalonyl-CoA accumulates and is converted to methylmalonic acid, which levels rise in serum (or urine). This makes methylmalonic acid a more specific indicator for B12 deficiency and helps distinguish it from folate deficiency, which does not elevate methylmalonic acid (though both deficiencies can raise homocysteine). The other options aren’t as specific: ferritin can be influenced by inflammation and iron stores, and LDH is a non-specific marker that doesn’t pinpoint B12 deficiency.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy